Norton Rose Fulbright has advised Velocity Clinical Research on the deal. Velocity Clinical Research (Velocity), a portfolio company of GHO Capital (Global Healthcare Opportunities), Europe’s leading...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented GHO Capital portfolio company Velocity Clinical Research on the deal. GHO Capital portfolio company Velocity Clinical Research announced the acquisition of Meridian Clinical...
You must be a Standard 1 Year member to access this content.
Reed Smith advised Velocity Clinical Research, Inc. in the deal. Velocity Clinical Research, Inc., a portfolio company of GHO Capital Partners, annunced its add-on acquisition of NRI Clinical...
You must be a Standard 1 Year member to access this content.
